Effective CAR T-cell targeting of an MUC1 cleavage product
Background We developed Chimeric antigen receptor (CAR) T cells targeting mucin 1 (MUC1)* (muk * (muk 1 star)), which is the tumor-associated growth factor receptor form of MUC1. Our antibody, MNC2, uniquely binds to MUC1* on cancer cells but does not bind to full-length MUC1, which is expressed on...
Saved in:
| Main Authors: | David D Smith, Benoit J Smagghe, Mark G Carter, Kevin R Yi, Jac-Leen S S Nash, Trevor J Grant, Dan S Miller, Scott T Moe, Michael J Nash, Natalie K Miller, Laura L Agarkov, Jacy P Marquez, Andrew K Stewart, Cynthia C Bamdad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e010577.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Wnt pathway induces a naïve-like subpopulation in primed stem cells, while NME7AB leads to a homogeneous naïve-like population.
by: Kevin R Yi, et al.
Published: (2025-01-01) -
Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
by: Jesús K. Yamamoto-Furusho, et al.
Published: (2015-01-01) -
MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
by: Zi Mei, et al.
Published: (2020-01-01) -
MUC1, MUC2, MUC4, MUC5AC, Cdx2: immunohistochemical characteristics in polyps and adenocarcinoma of distal colon
by: M. A. Shyshkin
Published: (2019-05-01) -
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01)